BLOOMINGTON, Ind. – Governor Eric Holcomb joined Simtra BioPharma Solutions (Simtra) executives and local officials this week to break ground on the company’s new state-of-the-art manufacturing facility in Monroe County.
In February, Simtra announced plans to expand its footprint in Bloomington by building a 150,000-square-foot manufacturing plant to house two high-speed automated isolator syringe fill lines and a new, high-speed isolator vial line equipped with three lyophilizers. The new facility will be supported by a $250 million investment and the creation of hundreds of new jobs.
“Indiana’s life sciences industry is on a roll,” said Holcomb. “Simtra’s investment in advancing critical R&D and delivering life-changing pharmaceuticals benefits people worldwide, grows Indiana’s economy, and creates high-quality careers for Hoosiers.”
Life sciences is a vital industry to Indiana’s economy, contributing $95 billion to the state’s economy annually and employing 67,000 people. Life sciences are also a source of venture capital funding with $910 million awarded to dozens of companies in 2022 and 2023.
Indiana’s life sciences ecosystem has experienced tremendous growth since 2021. Since 2021 $11.5 billion in committed capital has flowed into the state through 96 projects and 11,852 committed jobs.
Based on the company’s plans to create up to 130 jobs, the Indiana Economic Development Corporation committed an investment in Simtra BioPharma Solutions of up to $1.6 million in conditional tax credits. These incentives are performance-based, so the company can only claim state benefits once Hoosiers are hired and trained. Monroe County offered additional incentives.
